日本手术机器人系统市场 - 2025 至 2033 年

日本手术机器人系统市场在 2024 年达到 5.3962 亿美元，预计到 2033 年将达到 21.0776 亿美元，在 2025-2033 年的预测期内复合年增长率为 16.5%。

手术机器人系统是一种复杂而先进的医疗技术，由机器人设备、软体和仪器组成，旨在协助外科医生以更高的精度、灵活性和控制力执行手术程序。这些系统利用机械手臂、手术器械、视觉化技术和先进的控制系统，帮助外科医生以更有效、更少创伤的方式进行微创甚至传统开放性手术。

日本手术机器人系统市场经历了快速增长，这受到多种因素的推动，包括技术进步、对微创手术的需求不断增加以及对改善手术结果的关注。日本不同医疗机构对这些手术机器人系统的需求正在不断发展。例如，根据美国国立卫生研究院（NIH）统计，日本已有180多家机构安装了达文西手术系统。手术机器人系统的日益普及正在加速日本市场的需求。

市场动态：

驱动因素与约束因素

日本整形外科手术日益增多

日本外科手术的增加极大地推动了日本手术机器人系统市场的成长，预计将在预测期内推动市场的发展。日本人口老化迅速，65岁以上人口约占总人口的三分之一，约3,623万人，这一比例在主要经济体中最高。随着年龄的增长，人们通常需要接受复杂的手术来治疗心血管疾病、癌症、骨科疾病和脊椎疾病等。

例如，根据Springer Nature发表的文章，日本2022年共进行了61,606例心血管手术，其中包括120例VAD植入手术和79例心臟移植手术。此外，根据美国国立卫生研究院的数据，日本一年内进行了约 130 万例骨科住院手术。随着人口老化的加剧，预计手术量将会增加，这可能会增加日本对手术机器人系统的需求，以获得更好的手术效果。

由于人口老化，日本心血管疾病、癌症和糖尿病等慢性疾病的发生率不断上升。这些情况通常需要进行大手术，这在技术上具有挑战性并且对精度有很高的要求。慢性病负担的持续加重推动了对机器人辅助手术的需求，尤其是在肿瘤科、心臟科和泌尿科等专业领域。外科医生依靠机器人来执行这些复杂的手术，以获得更好的结果和更少的併发症，从而推动机器人系统的采用。

例如，根据日本临床肿瘤学会的数据，日本的癌症病例数一直在稳定增加，尤其是前列腺癌，它是发病的主要原因之一。根据东京国际大濠医院介绍，目前日本共有300多台机器人手术单位投入运行，每年实施超过1.3万例机器人辅助根治性摄护腺切除术。机器人辅助根治性摄护腺切除术、机器人辅助部分肾切除术等泌尿科机器人手术正快速普及。同样，在预测期内，其他手术（如骨科、心臟病学等）对手术机器人系统的需求也预计会上升。

来自传统手术系统的激烈竞争

传统手术系统的激烈竞争是阻碍日本手术机器人系统市场成长的因素之一。虽然机器人手术系统在精准度、微创手术和改善患者治疗效果方面具有显着优势，但由于成本、熟悉程度和初始投资较低等因素，传统手术方法在日本的许多手术中仍然占主导地位。

日本广泛采用机器人手术系统的主要障碍之一是初始成本高。达文西手术系统和美敦力 Hugo 系统等手术机器人系统的前期成本相当高，通常超过数百万美元。这些系统还需要昂贵的维护、训练和升级。

例如，单一达文西 Xi 手术系统的成本约为 100 万至 250 万美元，还不包括持续的维护和培训费用。相比之下，传统手术系统便宜得多，许多腹腔镜设备系统的价格为 50,000 至 200,000 美元，这使得小型医院和医疗机构更容易接受。

日本的外科医生普遍精通传统手术技术，尤其是在腹腔镜手术、骨科和一般外科等领域。这些技术已经很成熟，医疗专业人员也乐于使用它们。在日本，腹腔镜手术广泛应用于胃肠道手术，外科医生经验丰富且技术娴熟。

目录

第一章：市场介绍和范围

• 报告目标
• 报告范围和定义
• 报告范围

第 2 章：高阶主管见解与关键要点

• 市场亮点和战略要点
• 主要趋势和未来预测
• 按类型分类的程式码片段
• 按应用程式截取的程式码片段
• 最终用户的程式码片段

第 3 章：动态

• 影响因素
  • 驱动程式
    • 日本整形外科手术日益增多
  • 限制
    • 来自传统手术系统的激烈竞争
  • 机会
  • 影响分析

第四章：战略洞察与产业展望

• 市场领导者和先驱者
  • 新兴先锋和杰出参与者
  • 拥有最大销售品牌的成熟领导者
  • 拥有成熟产品的市场领导者
• CXO 观点
• 最新进展与突破
• 案例研究/正在进行的研究
• 监管和报销情况
• 波特五力分析
• 供应链分析
• SWOT 分析
• 未满足的需求和差距
• 市场进入和扩张的推荐策略
• 情境分析：最佳情况、基本情况和最坏情况预测
• 定价分析和价格动态
• 关键意见领袖

第 5 章：手术机器人系统市场（按类型）

• 机器人辅助手术系统
• 手术机械手臂
• 自主手术机器人

第 6 章：手术机器人系统市场（按应用）

• 骨科手术
• 妇科手术
• 泌尿科
• 心臟手术
• 神经外科
• 一般外科
• 其他的

第 7 章：手术机器人系统市场（以最终用户划分）

• 医院
• 门诊手术中心
• 专科诊所
• 其他的

第 8 章：竞争格局与市场定位

• 竞争概况和主要市场参与者
• 市占率分析与定位矩阵
• 策略伙伴关係、合併和收购
• 产品组合和创新的关键发展
• 公司基准化分析

第九章：公司简介

• Medicaroid Corporation
• 公司概况
• 产品组合和描述
• 财务概览
• 主要进展
• SWOT 分析
• Kawasaki Heavy Industries, Ltd.
• TELEXISTENCE Inc.
• Sony Group Corporation
• Intuitive Surgical
• Medtronic plc
• MicroPort Scientific Corporation
• Smith+Nephew
• ASAHI SURGICAL ROBOTICS CO., LTD.

第 10 章：假设与研究方法

• 资料收集方法
• 数据三角测量
• 预测技术
• 数据验证和确认

第 11 章：附录

The Japan surgical robot systems market reached US$ 539.62 million in 2024 and is expected to reach US$ 2,107.76 million by 2033, growing at a CAGR of 16.5% during the forecast period of 2025-2033.

A surgical robot system is a complex and advanced medical technology that consists of robotic devices, software, and instruments designed to assist surgeons in performing surgical procedures with greater precision, flexibility, and control. These systems use robotic arms, surgical instruments, visualization technologies, and advanced control systems to help surgeons conduct minimally invasive or even traditional open surgeries in a more effective and less invasive manner.

The Japan surgical robot systems Market has seen rapid growth driven by various factors, including advancements in technology, increasing demand for minimally invasive surgeries, and a focus on improving surgical outcomes. The demand for these surgical robot systems in Japan is evolving across different healthcare institutions. For instance, according to the National Institute of Health (NIH), more than 180 institutions have installed the da Vinci surgical system in Japan. This rising adoption of surgical robot systems is accelerating the market demand in Japan.

Market Dynamics: Drivers & Restraints

Rising surgical procedures in Japan

The rising surgical procedures in Japan is significantly driving the growth of the Japan surgical robot systems market and is expected to drive the market over the forecast period. Japan has a rapidly aging population, with almost a third of its population over 65, an estimated 36.23 million, the highest percentage among major economies. As people age, they often require complex surgeries for conditions like cardiovascular diseases, cancer, orthopedic issues, and spinal disorders.

For instance, according to the article published by Springer Nature, a total of 61,606 cardiovascular surgeries, including 120 VAD implantations and 79 heart transplants, were performed in 2022 in Japan. Additionally, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. As the aging population rises, the surgical procedure volume is expected to rise, which may create a demand for surgical robot systems in Japan for better outcomes.

Chronic diseases, such as cardiovascular conditions, cancer, and diabetes, are on the rise in Japan, primarily due to the aging population. These conditions often require major surgeries that can be technically challenging and require high precision. The rising burden of chronic diseases is propelling the demand for robot-assisted surgeries, especially in specialties like oncology, cardiology, and urology. Surgeons rely on robots to perform these complex procedures with better outcomes and fewer complications, driving the adoption of robotic systems.

For instance, according to the Japanese Society of Clinical Oncology, the number of cancer cases in Japan has been steadily increasing, particularly prostate cancer, which is one of the leading causes of morbidity. According to the Tokyo International Ohori Hospital, currently, more than 300 robot surgery units are in operation in Japan, and there have been performed more than 13,000 cases per year of robot-assisted radical prostatectomy. Urological robot surgery, such as robot-assisted radical prostatectomy and robot-assisted partial nephrectomy, is rapidly becoming widespread in Japan. Similarly, the demand for surgical robot systems in other surgeries like orthopedics, cardiology, etc, is expected to rise in the forecast period.

High competition from traditional surgical systems

The high competition from traditional surgical systems is one of the factors hampering the growth of the Japan surgical robot systems market. While robotic surgical systems offer significant advantages in precision, minimally invasive procedures, and improved patient outcomes, traditional surgical methods still dominate many procedures in Japan due to factors like cost, established familiarity, and lower initial investment.

One of the primary barriers to the widespread adoption of robotic surgery systems in Japan is the high initial cost. Surgical robot systems like the da Vinci Surgical System and the Medtronic Hugo System come with significant upfront costs, often exceeding several million dollars. These systems also require costly maintenance, training, and upgrades.

For instance, a single da Vinci Xi Surgical System costs approximately $1 to $2.5 million, not including ongoing maintenance and training costs. In comparison, traditional surgical systems are significantly cheaper, with many laparoscopic equipment systems costing $50,000 to $200,000, making them more accessible for smaller hospitals and healthcare facilities.

Surgeons in Japan are generally highly skilled with traditional surgical techniques, especially in fields like laparoscopic surgery, orthopedics, and general surgery. These techniques are well-established, and medical professionals are comfortable using them. In the field of laparoscopic surgery, which is widely used in Japan for gastrointestinal procedures, surgeons are highly experienced and proficient.

Segment Analysis

The Japan surgical robot systems market is segmented based on type, application, and end-user.

Application:

Orthopedic surgery dominates in the application segment of Japan's surgical robot systems, with the highest market share.

Japan has one of the oldest populations in the world, with almost a third of its population over 65, an estimated 36.23 million, according to the World Economic Forum. As people age, they are more prone to degenerative joint diseases, including osteoarthritis, spinal disorders, and hip and knee joint diseases, all of which require orthopedic surgery.

For instance, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. The demand for joint replacements (especially knee and hip replacements) is rising sharply due to the aging population. As a result, orthopedic surgeries are a major driver for robotic systems, which enhance the precision of joint replacements, reduce recovery times, and improve patient outcomes.

Robotic systems, such as the MAKO Robotic-Arm Assisted Surgery (by Stryker) and RAS (Robot-Assisted Surgery) for knee and hip replacements, are playing a crucial role in transforming orthopedic procedures. These systems offer higher precision during surgeries, better alignment of prosthetics, and improved patient outcomes, which are especially important in joint replacement surgeries.

For instance, the MAKO Robotic-Arm Assisted Surgery system has been increasingly adopted in Japan for knee and hip replacement surgeries. This system allows surgeons to customize procedures based on 3D imaging and offers a greater range of motion and more accurate alignment, resulting in fewer complications and faster recovery times for patients.

Competitive Landscape

The major players in the Japan surgical robot systems market include Medicaroid Corporation, Kawasaki Heavy Industries, Ltd., TELEXISTENCE Inc., Sony Group Corporation, Intuitive Surgical, Medtronic plc, MicroPort Scientific Corporation, Smith+Nephew, ASAHI SURGICAL ROBOTICS CO., LTD., and others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan surgical robot systems market report delivers a detailed analysis with 36 key tables, more than 30 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Application
• 2.5. Snippet by End-User

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising surgical procedures in Japan
  • 3.1.2. Restraints
    • 3.1.2.1. High competition from traditional surgical systems
  • 3.1.3. Opportunity
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. SWOT Analysis
• 4.9. Unmet Needs and Gaps
• 4.10. Recommended Strategies for Market Entry and Expansion
• 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.12. Pricing Analysis and Price Dynamics
• 4.13. Key Opinion Leaders

5. Surgical Robot Systems Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Robotic-Assisted Surgical Systems*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Surgical Robotic Arms
• 5.4. Autonomous Surgical Robots

6. Surgical Robot Systems Market, By Application

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 6.1.2. Market Attractiveness Index, By Application
• 6.2. Orthopedic Surgery*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Gynecology Surgery
• 6.4. Urological Surgery
• 6.5. Cardiac Surgery
• 6.6. Neurosurgery
• 6.7. General Surgery
• 6.8. Others

7. Surgical Robot Systems Market, By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Ambulatory Surgical Centers
• 7.4. Specialty Clinics
• 7.5. Others

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers, & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Medicaroid Corporation*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio and Description
  • 9.1.3. Financial Overview
  • 9.1.4. Key Developments
  • 9.1.5. SWOT Analysis
• 9.2. Kawasaki Heavy Industries, Ltd.
• 9.3. TELEXISTENCE Inc.
• 9.4. Sony Group Corporation
• 9.5. Intuitive Surgical
• 9.6. Medtronic plc
• 9.7. MicroPort Scientific Corporation
• 9.8. Smith+Nephew
• 9.9. ASAHI SURGICAL ROBOTICS CO., LTD.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us